150 related articles for article (PubMed ID: 2752105)
1. Microenvironmental toxicity of azidothymidine: partial sparing with hemin.
Abraham NG; Bucher D; Niranjan U; Brown AC; Lutton JD; Distenfeld A; Ahmed T; Levere RD
Blood; 1989 Jul; 74(1):139-44. PubMed ID: 2752105
[TBL] [Abstract][Full Text] [Related]
2. Specificity of heme for hemopoietic recovery from AZT toxicity.
Loewy G; Cook P; Ahmed T; Lutton JD; Nishimura M; Distenfeld A; Levere RD; Abraham NG
Hematol Pathol; 1992; 6(2):79-85. PubMed ID: 1607343
[TBL] [Abstract][Full Text] [Related]
3. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
Gallicchio VS; Hughes NK; Hulette BC; Noblitt L
J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of azidothymidine-induced erythroid toxicity by hemin and stem cell factor in immune-suppressed mice.
Hamburger AW; Chen RB
Exp Hematol; 1994 Apr; 22(4):348-52. PubMed ID: 7512046
[TBL] [Abstract][Full Text] [Related]
5. Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1.
Abraham NG; Chertkov JL; Staudinger R; Jiang S; Lutton JD; Argani I; Levere RD; Kappas A
Exp Hematol; 1993 Feb; 21(2):263-8. PubMed ID: 7678812
[TBL] [Abstract][Full Text] [Related]
6. Hemopoietic recovery from AZT toxicity with recombinant hemoglobin in a murine model of AIDS.
Moqattash S; Lutton JD; Abu-Hijleh MF; Abraham NG
Acta Haematol; 1994; 92(4):182-6. PubMed ID: 7701915
[TBL] [Abstract][Full Text] [Related]
7. Additive effect of erythropoietin and heme on murine hematopoietic recovery after azidothymidine treatment.
Harrison J; Kappas A; Levere RD; Lutton JD; Chertkov JL; Jiang S; Abraham NG
Blood; 1993 Dec; 82(12):3574-9. PubMed ID: 8260696
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of azidothymidine, 2'-3'-dideoxyadenosine, and 2'-3'-dideoxycytidine on in vitro growth of hematopoietic progenitor cells from normal persons and from patients with AIDS.
Ganser A; Greher J; Völkers B; Staszewski S; Hoelzer D
Exp Hematol; 1989 May; 17(4):321-5. PubMed ID: 2540017
[TBL] [Abstract][Full Text] [Related]
9. Role of heme metabolism in AZT-induced bone marrow toxicity.
Lutton JD; Mathew A; Levere RD; Abraham NG
Am J Hematol; 1990 Sep; 35(1):1-5. PubMed ID: 2389764
[TBL] [Abstract][Full Text] [Related]
10. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
Scheding S; Media JE; Nakeff A
Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
[TBL] [Abstract][Full Text] [Related]
11. Protection and rescue from 2',3'-dideoxypyrimidine nucleoside analog toxicity by hemin in human bone marrow progenitor cells.
Fowler DA; Xie MY; Sommadossi JP
Antimicrob Agents Chemother; 1996 Jan; 40(1):191-5. PubMed ID: 8787904
[TBL] [Abstract][Full Text] [Related]
12. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
Gallicchio VS; Hughes NK; Tse KF
Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
[TBL] [Abstract][Full Text] [Related]
13. Effects of combinations of stem cell factor and hemin on erythropoiesis after azidothymidine treatment of immunosuppressed mice.
Hamburger AW
Eur J Haematol; 1996 Aug; 57(2):128-33. PubMed ID: 8856089
[TBL] [Abstract][Full Text] [Related]
14. Synergistic cytotoxic effect of azidothymidine and recombinant interferon alpha on normal human bone marrow progenitor cells.
Berman E; Duigou-Osterndorf R; Krown SE; Fanucchi MP; Chou J; Hirsch MS; Clarkson BD; Chou TC
Blood; 1989 Sep; 74(4):1281-6. PubMed ID: 2765664
[TBL] [Abstract][Full Text] [Related]
15. Azidothymidine and interferon-alpha in vitro effects on hematopoiesis: protective in vitro activity of IL-1 and GM-CSF.
Castello G; Mela G; Cerruti A; Mencoboni M; Lerza R
Exp Hematol; 1995 Dec; 23(13):1367-71. PubMed ID: 7498365
[TBL] [Abstract][Full Text] [Related]
16. Protection of 3'-azido-3'-deoxythymidine induced toxicity to murine hematopoietic progenitors (CFU-GM, BFU-E and CFU-MEG) with interleukin-1.
Gallicchio VS; Doukas MA; Hulette BC; Hughes NK; Gass C
Proc Soc Exp Biol Med; 1989 Nov; 192(2):201-4. PubMed ID: 2813453
[TBL] [Abstract][Full Text] [Related]
17. Suppression of murine hematopoiesis in vivo after chronic administration of zidovudine: evidence that zidovudine-induced anemia is the result of decreased bone marrow-derived, erythropoietin-responsive progenitor cells.
Gallicchio VS; Hughes NK
Proc Soc Exp Biol Med; 1992 Apr; 199(4):459-65. PubMed ID: 1549625
[TBL] [Abstract][Full Text] [Related]
18. [Demonstration of a protector effect of interleukin-1 against hematologic toxicity of azidothymidine (AZT)].
Arock M; Dedenon A; Damais C; Averlant G; Guillosson JJ
C R Seances Soc Biol Fil; 1992; 186(3):206-14. PubMed ID: 1493577
[TBL] [Abstract][Full Text] [Related]
19. Comparison of dideoxynucleoside drugs (DDI and zidovudine) and induction of hematopoietic toxicity using normal human bone marrow cells in vitro.
Gallicchio VS; Hughes NK; Tse KF
Int J Immunopharmacol; 1993 Feb; 15(2):263-8. PubMed ID: 8468123
[TBL] [Abstract][Full Text] [Related]
20. Specificity of hemin action in vivo at early stages of hematopoietic cell differentiation.
Monette FC; Holden SA; Sheehy MJ; Matzinger EA
Exp Hematol; 1984 Nov; 12(10):782-7. PubMed ID: 6510480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
